Morgan Stanley Boosts Boston Scientific (NYSE:BSX) Price Target to $92.00
Boston Scientific (NYSE:BSX – Free Report) had its price objective hoisted by Morgan Stanley from $79.00 to $92.00 in a research report released on Monday morning, Benzinga reports. Morgan Stanley currently has an overweight rating on the medical equipment provider’s stock. BSX has been the topic of several other research reports. Evercore ISI lifted their […]
More Stories
Neurogene (NASDAQ:NGNE) Price Target Raised to $60.00
Neurogene (NASDAQ:NGNE – Free Report) had its price objective upped by Stifel Nicolaus from $44.00 to $60.00 in a research...
Tokio Marine Asset Management Co. Ltd. Has $2.52 Million Stock Position in Intercontinental Exchange, Inc. (NYSE:ICE)
Tokio Marine Asset Management Co. Ltd. raised its holdings in shares of Intercontinental Exchange, Inc. (NYSE:ICE – Free Report) by...
Valley Wealth Managers Inc. Purchases 8,833 Shares of Tapestry, Inc. (NYSE:TPR)
Valley Wealth Managers Inc. lifted its position in Tapestry, Inc. (NYSE:TPR – Free Report) by 2.1% during the 3rd quarter,...
Archer Investment Corp Lowers Stock Holdings in Tesla, Inc. (NASDAQ:TSLA)
Archer Investment Corp decreased its position in shares of Tesla, Inc. (NASDAQ:TSLA – Free Report) by 7.3% during the third...
WW International (NASDAQ:WW) Upgraded at StockNews.com
StockNews.com upgraded shares of WW International (NASDAQ:WW – Free Report) from a sell rating to a hold rating in a...
Applied Materials (NASDAQ:AMAT) Shares Gap Down Following Analyst Downgrade
Applied Materials, Inc. (NASDAQ:AMAT – Get Free Report)’s share price gapped down prior to trading on Friday after Bank of...